Skip to main content
Clinical Trials/ISRCTN93700442
ISRCTN93700442
Completed
Not Applicable

Impact of comprehensive and intensive treatment of risk factors concerning cardiovascular mortality in secondary prevention: MIRVAS study - a randomised controlled trial

a Princesa University Hospital (Hospital Universitario de La Princesa) (Spain)0 sites247 target enrollmentFebruary 19, 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Secondary prevention of cardiovascular disease
Sponsor
a Princesa University Hospital (Hospital Universitario de La Princesa) (Spain)
Enrollment
247
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 19, 2009
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
a Princesa University Hospital (Hospital Universitario de La Princesa) (Spain)

Eligibility Criteria

Inclusion Criteria

  • 1\. Both males and females, from 18 to 80 years old
  • 2\. Patients admitted to the hospital for acute coronary syndrome (with or without ST\-segment elevation) or an ischaemic stroke

Exclusion Criteria

  • 1\. Refusal or inability to participate in the follow\-up (displaced patients or with reduced mobility)
  • 2\. Life expectancy of less than 12 months
  • 3\. Severe cognitive deterioration

Outcomes

Primary Outcomes

Not specified

Similar Trials